LXG.H — Lexagene Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Lexagene Holdings, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
2018 February 28th | 2019 February 28th | C2020 February 29th | 2021 February 28th | 2022 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.01 | -8.32 | -7.5 | -9.89 | -10.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.431 | 2.08 | 1.69 | 1.04 | 1.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.108 | 0.107 | -0.113 | -0.713 | -0.549 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.66 | -6 | -5.41 | -9.04 | -9.65 |
| Capital Expenditures | -0.673 | -0.141 | -0.064 | -0.068 | -0.018 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.673 | -0.141 | -0.064 | -0.068 | -0.018 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6 | 4.21 | 8.14 | 15.5 | 4.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.78 | -1.98 | 2.51 | 6.44 | -4.9 |